Estrella Immunopharma (ESLA) Interest Coverage Ratio: History & Chart

Estrella Immunopharma, Inc.(ESLA)

Biotechnology · EmeryVille, CA

$0.44-0.03 (-5.98%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About Estrella Immunopharma, Inc.

Estrella Immunopharma, Inc. is an early-stage biopharmaceutical enterprise focused on creating T-cell therapies for various blood cancers and solid tumors, with its primary activities centered in the United States. The company's lead investigational drugs include EB103, which is in preclinical development for diffuse large B-cell lymphoma, and EB104, intended for the treatment of both diffuse large B-cell lymphoma and acute lymphocytic leukemia. Estrella also maintains a collaborative agreement with Imugene Limited, working together to develop solid tumor therapies that integrate Imugene's CF33-CD19t product candidate with Estrella's EB103. The company is based in Emeryville, California.

EmeryVille, CA

3 employees

www.estrellabio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Cheng Liu

View full financials

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Estrella Immunopharma, Inc. (ESLA)	$18.77M	N/A	N/A	N/A	N/A
Cosmos Health Inc. (COSM)vs ›	$18.82M	-6.31x	0.97x	0.97x	0.97x
Actuate Therapeutics Inc (ACTU)vs ›	$20.93M	-1110.88x	1344.27x	1344.27x	1344.27x
Bionano Genomics, Inc. (BNGO)vs ›	$16.58M	-111.88x	N/A	N/A	N/A
Dyadic International, Inc. (DYAI)vs ›	$16.54M	-15.67x	0.81x	0.81x	0.81x
BioCardia, Inc. (BCDA)vs ›	$16.22M	N/A	N/A	N/A	N/A
Allarity Therapeutics, Inc. (ALLR)vs ›	$15.91M	-68.14x	N/A	N/A	N/A
Aytu BioPharma, Inc. (AYTU)vs ›	$21.90M	4.39x	4.39x	4.39x	4.39x
Cocrystal Pharma, Inc. (COCP)vs ›	$15.30M	N/A	N/A	N/A	N/A
Pasithea Therapeutics Corp. (KTTA)vs ›	$15.20M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Estrella Immunopharma, Inc. (ESLA)

$18.77M

N/A

Cosmos Health Inc. (COSM)vs ›

$18.82M

-6.31x

0.97x

Actuate Therapeutics Inc (ACTU)vs ›